Indefinite Delivery Contract 12639526D0012

This single-award Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a small business subsidiary of Opko Health, Inc. The contract has a ceiling value of $2,530,960 and a period of performance through June 30, 2026. The contract is for Genedx to provide a wide range of genetic testing services to support NIH's clinical research and patient care programs. Services include mutation analysis, exome and genome sequencing, gene...

This Blanket Purchase Agreement (BPA) contract, awarded by the U.S. Department of Health and Human Services to Genewiz, LLC, a subsidiary of Azenta, Inc., provides a range of genomic services to support scientific research initiatives at various federal civilian agencies. The contract covers a variety of next-generation sequencing capabilities, including whole genome, whole exome, transcriptome, and single cell sequencing, as well as PCR, library preparation, data analysis, and sample...

This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency within the Department of Health and Human Services, to the prime contractor Transnetyx, Inc. The $30,000 BPA is for the provision of genotyping and genetic monitoring services, with a period of performance from March 2025 to February 2027. Transnetyx, a for-profit organization specializing in automated genotyping, DNA extraction,...

This Blanket Purchase Agreement (BPA) contract, awarded by the U.S. Department of Health and Human Services (HHS) to Integrated DNA Technologies, Inc. (IDT), enables the procurement of specialized biological products and services. Key deliverables include custom oligonucleotide synthesis, gene fragments, next-generation sequencing reagents, and other molecular biology tools. The contract supports a diverse range of federal agencies, including the National Institutes of Health (NIH), Centers...

This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The contract has a ceiling value of $5,000,000 and a period of performance through September 16, 2029. Under this BPA, IDT will deliver a variety of custom oligonucleotides, including DNA and RNA, gene fragments, next-generation sequencing products, primers, probes, and...

This federal contract Indefinite Delivery Vehicle (IDV) is a single-award contract awarded to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The $375,000 IDV was awarded by the Department of Veterans Affairs (VA) for automated genotyping services to support animal research at the San Francisco VA Healthcare System. The contract includes a 12-month base period from June 24, 2025, to June 23, 2026, with four one-year option periods. Task...

This single-award IDV was issued by the Department of Health and Human Services National Institutes of Health Clinical Center to provide mutation analysis services. The potential value of the contract is $250,000. The prime contractor is Genedx, LLC of Gaithersburg, Maryland. The original solicitation sought continuation of existing mutation analysis testing services for the NIH Department of Laboratory Medicine. Due to the impacts of COVID-19, the final assessment of a previous contract was not...

This Indefinite Delivery Contract (IDC) was awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $243,308 single-award contract has a period of performance ending on June 4, 2013. Under this IDC, Illumina provides a range of genomic sequencing systems, consumables, and bioinformatics products to support research and...

This Indefinite Delivery Contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract, which has a total ceiling value of $540,311.66, is for the provision of MIRCURY LNA MIRNA FOCUS PCR PANELS and POLYMERASE CHAIN REACTION (PCR) 384-WELL PLATES to support MEDCOM's biomedical research, public health, and healthcare programs. The contract is a single-award, with no set-aside designation, and...

This indefinite delivery contract was awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Autogen Inc., a self-certified small disadvantaged business. The $162,800 single-award contract has an ultimate completion date of August 13, 2013 and aims to procure Autogen's FLEXIGENE 5ML FRESH AND FROZEN WHOLE BLOOD PROTOCOLS, which utilize the company's AUTOGEN FLEX STAR automated DNA/RNA extraction instruments. The...